44 R.G. Pertwee
Helyes Z, Németh J, Thán M, Bölcskei K, Pintér E, Szolcsányi J (2003) Inhibitory effect
of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and
neuropathic hyperalgesia in the rat. Life Sci 73:2345–2353
Hermann H, De Petrocellis L, Bisogno T, Schiano Moriello A, Lutz B, Di Marzo V (2003) Dual
effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated
response. Cell Mol Life Sci 60:607–616
Hillard CJ (2000) Biochemistry and pharmacology of the endocannabinoids arachidonyl-
ethanolamide and 2-arachidonylglycerol. Prostaglandins Other Lipid Mediat 61:3–18
Hillard CJ, Jarrahian A (2003) Cellular accumulation of anandamide: consensus and con-
troversy. Br J Pharmacol 140:802–808
HillardCJ,MannaS,GreenbergMJ,DicamelliR,RossRA,StevensonLA,MurphyV,Pertwee
RG, Campbell WB (1999) Synthesis and characterization of potent and selective agonists
of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 289:1427–1433
Hirst RA, Almond SL, Lambert DG (1996) Characterisation of the rat cerebella CB1 receptor
using SR141716A, a central cannabinoid receptor antagonist. Neurosci Lett 220:101–104
Ho W-SV, Hiley CR (2003) Vasodilator actions of abnormal-cannabidiol in rat isolated small
mesenteric artery. Br J Pharmacol 138:1320–1332
Howlett AC (1987) Cannabinoid inhibition of adenylate cyclase: relative activity of con-
stituents and metabolites of marihuana. Neuropharmacology 26:507–512
Howlett AC, Fleming RM (1984) Cannabinoid inhibition of adenylate cyclase. Pharmacology
of the response in neuroblastoma cell membranes. Mol Pharmacol 26:532–538
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M,
Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Phar-
macology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161–202
Huffman JW, Yu S, Showalter V, Abood ME, Wiley JL, Compton DR, Martin BR, Bramblett
RD, Reggio PH (1996) Synthesis and pharmacology of a very potent cannabinoid lacking
a phenolic hydroxyl with high affinity for the CB2 receptor. J Med Chem 39:3875–3877
Huffman JW, Liddle J, Yu S, Aung MM, Abood ME, Wiley JL, Martin BR (1999) 3-(1’,1’-
dimethylbutyl)-1-deoxy-∆8-THC and related compounds: synthesis of selective ligands
for the CB2 receptor. Bioorg Med Chem 7:2905–2914
Huffman JW, Bushell SM, Miller JRA, Wiley JL, Martin BR (2002) 1-methoxy-, 1-deoxy-11-
hydroxy- and 11-hydroxy-1-methoxy-∆8-tetrahydrocannabinols: new selective ligands
for the CB2 receptor. Bioorg Med Chem 10:4119–4129
Hurst DP, Lynch DL, Barnett-Norris J, Hyatt SM, Seltzman HH, Zhong M, Song Z-H, Nie
J, Lewis D, Reggio PH (2002) N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichloro-
phenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS
3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor. Mol Phar-
macol 62:1274–1287
Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, Vanderah TW, Lai J,
Porreca F, Makriyannis A, Malan TP (2003) Activation of CB2 cannabinoid receptors
by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not
present in the CNS. Proc Natl Acad Sci USA 100:10529–10533
Iversen L (2003) Cannabis and the brain. Brain 126:1252–1270
Iwamura H, Suzuki H, Ueda Y, Kaya T, Inaba T (2001) In vitro and in vivo pharmacological
characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.
J Pharmacol Exp Ther 296:420–425
Izzo AA, Mascolo N, Tonini M, Capasso F (2000) Modulation of peristalsis by cannabinoid
CB1 ligands in the isolated guinea-pig ileum. Br J Pharmacol 129:984–990
Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI,
Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G (1999) Cannabinoid-induced
mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Proc Natl Acad Sci USA 96:14136–14141
Jarrahian A, Manna S, Edgemond WS, Campbell WB, Hillard CJ (2000) Structure-activity
relationships among N-arachidonylethanolamine (anandamide) head group analogues
for the anandamide transporter. J Neurochem 74:2597–2606